APA (7th ed.) Citation

KP, P., MR, S., R, D., I, C., E, R., L, S., . . . A, S. (2026). Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumors. European journal of cancer (Oxford, England : 1990), 242, 116792. https://doi.org/10.1016/j.ejca.2026.116792

Chicago Style (17th ed.) Citation

KP, Papadopoulos, et al. "Debio 0123, a WEE1 Kinase Inhibitor: Phase 1 Results from Dose Escalation in Patients with Advanced Solid Tumors." European Journal of Cancer (Oxford, England : 1990) 242 (2026): 116792. https://doi.org/10.1016/j.ejca.2026.116792.

MLA (9th ed.) Citation

KP, Papadopoulos, et al. "Debio 0123, a WEE1 Kinase Inhibitor: Phase 1 Results from Dose Escalation in Patients with Advanced Solid Tumors." European Journal of Cancer (Oxford, England : 1990), vol. 242, 2026, p. 116792, https://doi.org/10.1016/j.ejca.2026.116792.